Review finds evidence does not back use of treatment for 16 and 17-year-olds with gender incongruence or dysphoriaThe NHS is pausing new referrals for masculinising or feminising hormone treatment for 16 and 17-year-olds after an in-depth review found there was insufficient evidence to support its continued use.Prescriptions for hormones had been available in England for under-18s with a diagnosis of gender incongruence or dysphoria who met certain criteria. Continue reading...
Review finds evidence does not back use of treatment for 16 and 17-year-olds with gender incongruence or dysphoria
The NHS is pausing new referrals for masculinising or feminising hormone treatment for 16 and 17-year-olds after an in-depth review found there was insufficient evidence to support its continued use.
Prescriptions for hormones had been available in England for under-18s with a diagnosis of gender incongruence or dysphoria who met certain criteria.
Continue reading...
NHS trusts also report disruption to supplies last winter of co-codamol and blood pressure medication ramiprilHospitals...
In today’s newsletter: New details suggest there is a counter-narrative to how events unfolded at the airbase used by th...
Sir Andrew Dilnot, who proposed reforms 15 years ago, says the cost of such a scheme would be "very substantial".
Work and pensions secretary says the current system is flawed because it consigns too many people to a life on benefits...
Family doctors’ professional body finds the majority have no time to discuss preventative measures A friendly chat with...
The prime minister told the BBC that social care in England is "as unfair as American healthcare".
No other articles in this category yet.
